Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fournier

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Thescientificworldjournal|September 7, 2004
Ammonia emission and deposition in Scotland and its potential environmental impactsM A Sutton, U Dragosits, S Hellsten, et al.
The Canadian Journal of Cardiology|November 12, 2025
Anteroposterior vs Anterolateral Shock Vectors for Atrial Fibrillation Cardioversion: Design and Rationale of the SHOCK-VECTOR TrialRubani S Suri, W F McIntyre, E P Belley-Cote, et al.
Molecular Neurodegeneration|May 15, 2025
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisAdam N Trautwig, Edward J Fox, Eric B Dammer, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
JAMA Network Open|February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialSabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Thescientificworldjournal|September 7, 2004
Ammonia emission and deposition in Scotland and its potential environmental impactsM A Sutton, U Dragosits, S Hellsten, et al.
The Canadian Journal of Cardiology|November 12, 2025
Anteroposterior vs Anterolateral Shock Vectors for Atrial Fibrillation Cardioversion: Design and Rationale of the SHOCK-VECTOR TrialRubani S Suri, W F McIntyre, E P Belley-Cote, et al.
Molecular Neurodegeneration|May 15, 2025
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisAdam N Trautwig, Edward J Fox, Eric B Dammer, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
JAMA Network Open|February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialSabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
Pageof 11